INTRODUCTION & AIM OF THE WORKSHOP

On 27 and 28 April, the 2nd EBF Cyberconnect Event in 2021 will continue our journey on Biomarkers. After 2 consecutive Focus Workshop reconnecting the bioanalytical community with the EBF recommendations on Biomarker Assay validation and the principles of context of use (CoU), the EBF will increase its efforts on bringing CoU into practice by connecting the bioanalytical scientist with the end users of the data around case studies.

CALL FOR SPEAKERS

For this Focus Workshop, we will be issuing a limited call for speakers.

We invite experts willing to share and discuss the practical advantages of a priori/continued bidirectional stakeholder interactions or, in contracts, the pitfalls of absent, late or inadequate communication.

You can submit your abstract with a short resume of your anticipated contribution before 26JAN2021 using this submission form to focus@e-b-f.eu.

Inclusion into the program will be evaluated by the organising committee and is based on its fit with the meeting goals. The workshop will have room for a maximum of 4 submitted case studies. We will communicate acceptance of your abstract before 31JAN2021

MEETING AGENDA

Agenda details will be communicated later – for your calendar planning, the meeting will be from 12:30 CET – 17:30 CET on both 27 and 28 April (2 half days, trying to reasonably favour NA and Asia time zones too). Each session will include a combination of plenary presentations, case studies and Q&A moments

The meeting will be running on the Zoom platform. Based the positive experience from our recent cybermeetings, we plan to include smaller breakouts to increase interactive discussions and learning opportunities.

WHO SHOULD ATTEND?

Scientists and managers from Pharma R&D, CRO and Health Authorities involved in the challenges of Biomarker assay validation, stakeholder communication or, in general, bringing the principles of CoU into practice.

CALL FOR REGISTRATION

Web-registration (full registration fee of 225 Euro)

To register: use this link

Meeting Organisation

Organising Committee: : Kyra Cowan (Covance), Ulrich Kunz (Boehringer Ingelheim), Robert Nelson (Covance), Michaela Golob (Nuvisan), Joanne Goodman (AstraZeneca), and Philip Timmerman (EBF)